Highly variable pharmacokinetics of dexmedetomidine during intensive care: a case report

INTRODUCTION: Dexmedetomidine is a selective and potent alpha2-adrenoceptor agonist licensed for use in the sedation of patients initially ventilated in intensive care units at a maximum dose rate of 0.7 μg/kg/h administered for up to 24 hours. Higher dose rates and longer infusion periods are somet...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Iirola, Timo, Laitio, Ruut, Kentala, Erkki, Aantaa, Riku, Kurvinen, Juha-Pekka, Scheinin, Mika, Olkkola, Klaus T
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Case report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2848065/
https://ncbi.nlm.nih.gov/pubmed/20184754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-4-73
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars